| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |